News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,788 Results
Type
Article (13645)
Company Profile (108)
Press Release (249035)
Section
Business (87973)
Career Advice (464)
Deals (15334)
Drug Delivery (64)
Drug Development (36556)
Employer Resources (49)
FDA (6271)
Job Trends (6189)
News (150089)
Policy (14016)
Tag
Academia (435)
Alliances (23169)
Alzheimer's disease (371)
Approvals (6282)
Artificial intelligence (73)
Bankruptcy (144)
Best Places to Work (4356)
Breast cancer (64)
Cancer (448)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (61)
Clinical research (30624)
Collaboration (232)
Compensation (96)
COVID-19 (751)
C-suite (76)
Data (446)
Diabetes (64)
Diagnostics (1249)
Drug discovery (45)
Drug pricing (59)
Earnings (31630)
Events (37005)
Executive appointments (263)
FDA (6537)
Funding (153)
Gene therapy (72)
GLP-1 (314)
Government (1273)
Healthcare (3542)
Infectious disease (773)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5848)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3417)
Lung cancer (64)
Manufacturing (113)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9589)
Metabolic disorders (199)
Neuroscience (494)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (548)
Obesity (119)
Opinion (113)
Patents (70)
People (28646)
Pharmaceutical (67)
Phase I (7973)
Phase II (12945)
Phase III (11633)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (115)
Real estate (2631)
Regulatory (9926)
Research institute (563)
Resumes & cover letters (55)
Southern California (532)
Startups (1625)
United States (5334)
Vaccines (120)
Weight loss (86)
Date
Today (50)
Last 7 days (148)
Last 30 days (710)
Last 365 days (12365)
2025 (633)
2024 (12507)
2023 (14247)
2022 (19558)
2021 (20068)
2020 (19034)
2019 (14888)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (45)
Asia (19935)
Australia (2573)
California (1279)
Canada (719)
China (169)
Colorado (51)
Connecticut (54)
Europe (39016)
Florida (213)
Illinois (145)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (188)
Massachusetts (1109)
Minnesota (70)
New Jersey (528)
New York (358)
North Carolina (317)
Northern California (548)
Pennsylvania (337)
South America (500)
Southern California (532)
Texas (169)
Virginia (49)
Washington State (85)
262,788 Results for "avadel pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
January 3, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 13, 2024
·
1 min read
Avadel Pharmaceuticals to Present at Upcoming June 2024 Investor Conferences
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced that members of management will participate in the following upcoming investor conferences.
May 30, 2024
·
1 min read
Avadel Pharmaceuticals to Join Russell 3000® Index - June 27, 2024
Avadel Pharmaceuticals plc announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted Friday, May 24, 2024.
June 27, 2024
·
3 min read
Press Releases
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
January 9, 2025
·
12 min read
Business
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024.
May 21, 2024
·
4 min read
Press Releases
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
October 25, 2024
·
5 min read
Press Releases
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
November 4, 2024
·
1 min read
Business
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, provided a corporate update and announced its financial results for the quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - March 5, 2024
Avadel Pharmaceuticals plc announced today that members of management will participate in the following upcoming investor conferences.
March 5, 2024
·
1 min read
1 of 26,279
Next
